Daniel Bergé

Pentoxifylline

The relationship between benign joint hypermobility syndrome and psychological distress: a systematic review and meta-analysis

Emotion Recognition in Borderline Personality Disorder—A Review of the Literature

Diclofenac residues as the cause of vulture population decline in Pakistan

Joint hypermobility syndrome: problems that require psychological intervention

Joint hypermobility syndrome is a risk factor trait for anxiety disorders: a 15-year follow-up cohort study

22q11.2 deletion syndrome

Neuroanatomical phenotypes in a mouse model of the 22q11.2 microdeletion

COX-2 inhibitors

Joint Hypermobility, Anxiety and Psychosomatics: Two and a Half Decades of Progress Toward a New Phenotype

Guidelines for the Early Management of Adults With Ischemic Stroke

Association between Psychopathological Factors and Joint Hypermobility Syndrome in a Group of Undergraduates from a French University

The sounds of science - A symphony for many instruments and voices

Psychiatric and psychological aspects in the Ehlers–Danlos syndromes

Occurrence of drugs in German sewage treatment plants and rivers

Cyclooxygenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines.

Neural correlates of impaired emotional discrimination in borderline personality disorder: An fMRI study

Gray matter volume deficits and correlation with insight and negative symptoms in first-psychotic-episode subjects

The relationship between frequency and intensity of fears and a collagen condition

[The effects of pentoxifylline on microcirculatory changes in the course of arterial diseases (arterial hypertension, diabetes). The value of conjunctival biomicroscopy].